Should You Buy Check Point Software Technologies Ltd (CHKP) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
CHKP is not a good buy right now for a beginner, long-term investor who wants to put money to work immediately. The stock’s trend is currently bearish (weak moving-average setup and negative MACD), hedge funds have been net sellers, and there are no fresh news catalysts supporting near-term momentum ahead of earnings (2026-02-12). While the business is performing well fundamentally (Q3’25 strong EPS and net income growth), the current tape suggests you’re more likely buying into continued drift/lower prices than into an uptrend.
Technical Analysis
Price/Trend: Bearish trend condition with SMA_200 > SMA_20 > SMA_5 (downtrend across short/medium/long timeframes). Momentum: MACD histogram at -0.218 (below zero) but negatively contracting, implying downside momentum is easing but has not flipped bullish. RSI(6)=45.06 (neutral), consistent with a weak/indecisive phase rather than a confirmed rebound. Key levels: Pivot 183.376 is immediate overhead resistance; price (~180.84) is below pivot, so rallies may stall there. Support sits at S1 175.663 (then S2 170.898). A constructive technical improvement would be reclaiming ~183.4 and holding above it; failure increases odds of testing 175.7/170.9. Quant pattern read-through: Similar-pattern stats imply modest negative bias (-0.41% next week, -2.26% next month), aligning with the current bearish MA stack.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Analyst Ratings and Price Target Trends
Recent trend: Multiple firms lowered price targets in early January (RBC 215->195, Barclays 235->220, Piper 260->240, Truist 250->225, Scotiabank 210->195). Citi was the exception in December, raising to 210 from 200 while staying Neutral. Ratings mix: Buy/Overweight (Truist, Piper) vs Neutral/Equal Weight/Sector Perform (Citi, Barclays, RBC, Scotiabank). Wall Street pros: defensive cybersecurity demand, potential for steady execution and earnings beats. Cons: less compelling AI narrative vs peers, sector rotation pressure, and a more cautious valuation/target reset cycle. Influential trading check: No recent congress trading data available; insiders reported as neutral and no significant insider trend over the last month.
Wall Street analysts forecast CHKP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHKP is 227.67 USD with a low forecast of 195 USD and a high forecast of 285 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast CHKP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHKP is 227.67 USD with a low forecast of 195 USD and a high forecast of 285 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 180.240
Current: 180.240
